The Immune System's Response to Young Women's Breast Cancer
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT01503190
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Cancer and Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study plans to learn more about the immune system's response to breast cancer in young women.
Key Dates
- Start date
- Jul 21, 2009
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2026
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 800 participants (estimated)
Primary Outcome Measure
Progression Free Survival [ Time Frame: Throughout study participation ]
Central Contacts
- Hannah Parris720-848-4170
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Denver | Aurora | Colorado | 80045 | Virginia Borges, MD, MMSc (PRINCIPAL_INVESTIGATOR) |
| Denver Health Hospital Authority | Denver | Colorado | 80204 | |
| UCHealth Cherry Creek Medcial Center | Denver | Colorado | 80206 | |
| UCHealth Highlands Ranch Hospital | Highlands Ranch | Colorado | 80129 | |
| UCHealth Lone Tree Medical Center | Lone Tree | Colorado | 80124 |
Find similar trials in Aurora, CO
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After LumpectomyPHASE3 · Recruiting · Rocky Mountain Cancer Centers · Aurora, Colorado
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama